NAPWA

The 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention was held in Rome last week from 17-20 July. This meeting is held every two years and alternates with the much larger World AIDS Conferences also organised by the International AIDS Society (IAS). read more »

Significant advances in HIV prevention were unveiled at the XVIII International AIDS Conference in Vienna, with research advancing on several fronts towards new prevention technologies. Paul Kidd reports. read more »

The 13th annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver, Colorado, from February 5 to 8. The major breaking news from this conference was the premature cancellation of the SMART study, but as usual, this important conference produced a great deal more than a single story. read more »

Kirsty Machon questions the misinformation, controversy and conspiracy theories which put an end to the proposed PREP trials among sex workers in Cambodia and Cameroon. read more »

A summary of current research into CD4 cell loss in early infection and its implications for HIV prevention, by NAPWA policy analyst Kirsty Machon. read more »

A controversial Cambodian trial of tenofovir for pre-exposure prophylaxis (PREP) is unlikely to proceed after sex workers and the Cambodian government claimed the trial did not include adequate safeguards for the health and human rights of the participants. read more »

Australian researchers have teamed up with the US and Cambodia to conduct a study of the potential of the HIV antiviralA medication or substance which is active against one or more virusesA small infective organism which is incapable of reproducing outside a host cell.. May include anti-HIV drugs, but these are more accurately termed antiretroviralsA medication or other substance which is active against retroviruses such as HIV.. tenofovir, taken daily, to prevent HIV infection in women at high risk. read more »